Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<b><i>Cannabis sativa</i></b> and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Milena de Barros Viana, Pedro Everson Alexandre de Aquino, Débora Estadella, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 207-219
Open Access | Times Cited: 20

Showing 20 citing articles:

Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 55
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 21
The Cannabinoids, CBDA and THCA, Rescue Memory Deficits and Reduce Amyloid-Beta and Tau Pathology in an Alzheimer’s Disease-like Mouse Model
Juyong Kim, Pilju Choi, Young‐Tae Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6827-6827
Open Access | Times Cited: 27
Cannabidiol and Neurodegeneration: From Molecular Mechanisms to Clinical Benefits
Saurabh Kumar Jha, Vinod K. Nelson, Punna Rao Suryadevara, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102386-102386
Closed Access | Times Cited: 8
Epidemiology and Health Impacts of Substance Use
Richard Alecsander Reichert, Flávia Zacouteguy Boos, Fernanda Machado Lopes, et al.
(2025), pp. 87-119
Closed Access
Current Drug Treatment for Acute and Recurrent Pericarditis
Aldo Bonaventura, Davide Santagata, Alessandra Vecchiè, et al.
Drugs (2025)
Open Access
Cannabidiol Protects Dopaminergic-like Neurons against Paraquat- and Maneb-Induced Cell Death through Safeguarding DJ-1CYS106 and Caspase 3 Independently of Cannabinoid Receptors: Relevance in Parkinson’s Disease
Miguel Mendivil‐Perez, Andrea A. Felizardo-Otalvaro, Marlene Jiménez-Del-Río, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2159-2171
Closed Access | Times Cited: 10
Diversity and variability of bioactive compounds in Cannabis sativa: Effects on therapeutic and environmental uses and orientations for future research
Maryem El Oihabi, Mohammed Soultana, Mohammed Ammari, et al.
Case Studies in Chemical and Environmental Engineering (2024) Vol. 9, pp. 100732-100732
Open Access | Times Cited: 3
A journey through cannabidiol in Parkinson’s disease
Elaine Aparecida Del Bel, Nubia Barros-Pereira, Rafaela Ponciano de Moraes, et al.
International review of neurobiology (2024), pp. 65-93
Closed Access | Times Cited: 2
Current chromatographic methods to determine cannabinoids in biological samples: a review of the state-of-the art on sample preparation techniques
Igor Gustavo Carvalho Oliveira, Caroline Fernandes Grecco, Israel Donizéti de Souza, et al.
Green Analytical Chemistry (2024) Vol. 11, pp. 100161-100161
Open Access | Times Cited: 2
The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials
Carly de Faria Coelho, Rodolfo P. Vieira, Osvaldo Soares Araújo-Junior, et al.
Life (2024) Vol. 14, Iss. 11, pp. 1373-1373
Open Access | Times Cited: 2
Recent advances in the development of CB1R selective probes
Arianna Amenta, Diego Caprioglio, Alberto Minassi, et al.
Frontiers in Natural Products (2023) Vol. 2
Open Access | Times Cited: 5
Artificial Intelligence in The Management of Neurodegenerative Disorders
Sanchit Dhankhar, Somdutt Mujwar, Nitika Garg, et al.
CNS & Neurological Disorders - Drug Targets (2023) Vol. 23, Iss. 8, pp. 931-940
Closed Access | Times Cited: 5
Phytocannabinoids in neuromodulation: From omics to epigenetics
Subhadip Banerjee, Debolina Saha, Rohit Sharma, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118201-118201
Closed Access | Times Cited: 1
Navigating neurological disorders: harnessing the power of natural compounds for innovative therapeutic breakthroughs.
Rapuru Rushendran, Rukaiah Fatma Begum, Ankul Singh S, et al.
PubMed (2024) Vol. 23, pp. 534-569
Closed Access | Times Cited: 1
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
Rafael Rivas‐Santisteban, Ana Muñoz, Jaume Lillo, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Health Care Providers’ Knowledge, Attitudes, and Practices Toward Medicinal Cannabis: The Case of Lebanon
Bassima Hazimeh, Ibrahim R. Bou-Orm, Mohamad Mroueh, et al.
Cannabis and Cannabinoid Research (2024)
Closed Access
New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer’s Disease Treatment
Violina T. Angelova, Boris Petrov Stoyanov, Rumyana Simeonova
Molecules (2024) Vol. 29, Iss. 22, pp. 5314-5314
Open Access
Plant-derived compounds and neurodegenerative diseases: Different mechanisms of action with therapeutic potential
Carolina Echeverry, Mariana Pazos, Maximiliano Torres-Pérez, et al.
Neuroscience (2024)
Closed Access
Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View
Flavia Padoan, Chiara Colombrino, Francesca Sciorio, et al.
Children (2023) Vol. 10, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 1
Page 1

Scroll to top